Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Share Issue/Capital Change 2020

Dec 24, 2020

3747_rns_2020-12-24_e3d9e4c0-4f28-4c2e-b6bf-8048cd4ae970.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Ny aksjekapital registrert

SoftOx Solutions AS: Ny aksjekapital registrert

SoftOx Solutions AS: New share capital registered

Reference is made to the previous stock exchange announcement from SoftOx Solutions AS (the "Company" or "SoftOx", ticker SOFTX) on 16 December 2020 regarding the successfully completed private placement.

The share capital increase pertaining to tranche 1 in the private placement of NOK 10,000 divided on 500,000 shares has today been registered in the Norwegian Register of Business Enterprises (Nw: Foretaksregisteret).

Following the share capital increase, the new share capital in the Company is NOK 166,598 divided into 8,329,900 shares, each with a nominal value of NOK 0.02.

The new shares will be listed and tradable on Euronext Growth Oslo from issuance in the Central Securities Depository (VPS).

For further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS

Mail: [email protected]

Mobile: +47 948 59 599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on the Oslo Stock Exchange Euronext Growth) is a Norwegian MedTech company based in Oslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com